{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:34:16Z","timestamp":1791977656888,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.tice.2025.102807","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:55:36Z","timestamp":1740124536000},"page":"102807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Enhancing prostate cancer cells\u2019 sensitivity to flutamide by resveratrol: An in-vitro study"],"prefix":"10.1016","volume":"94","author":[{"given":"Seyedeh Fatemeh","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Reza","family":"Yahyazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahil","family":"Mashhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helia Azodian","family":"Ghajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1611-0362","authenticated-orcid":false,"given":"Seyed Mohammad Kazem","family":"Aghamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.tice.2025.102807_bib1","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","article-title":"The Bcl-2 apoptotic switch in cancer development and therapy","volume":"26","author":"Adams","year":"2007","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.tice.2025.102807_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1158\/1535-7163.MCT-05-0526","article-title":"Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3\u2032-kinase\/Akt pathway and Bcl-2 family proteins","volume":"5","author":"Aziz","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.tice.2025.102807_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","article-title":"Therapeutic potential of resveratrol: the in vivo evidence","volume":"5","author":"Baur","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tice.2025.102807_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.991330","article-title":"Advances and development of prostate cancer, treatment, and strategies: a systemic review","volume":"10","author":"Belkahla","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.tice.2025.102807_bib5","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1854::AID-CNCR15>3.0.CO;2-Z","article-title":"Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?","volume":"77","author":"Bennett","year":"1996","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.tice.2025.102807_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/cjp2.202","article-title":"The epithelial-mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients","volume":"7","author":"B\u00f8rretzen","year":"2021","journal-title":"J. Pathol. Clin. Res"},{"issue":"5","key":"10.1016\/j.tice.2025.102807_bib7","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1039\/C6MB00186F","article-title":"Molecular insight into the differential anti-androgenic activity of resveratrol and its natural analogs: in silico approach to understand biological actions","volume":"12","author":"Chakraborty","year":"2016","journal-title":"Mol. Biosyst."},{"issue":"2","key":"10.1016\/j.tice.2025.102807_bib8","first-page":"607","article-title":"Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation","volume":"8","author":"Cho","year":"2002","journal-title":"Clin. Cancer Res"},{"issue":"12","key":"10.1016\/j.tice.2025.102807_bib9","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1177\/1535370215573396","article-title":"Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis","volume":"240","author":"Dun","year":"2015","journal-title":"Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.tice.2025.102807_bib10","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/106002809002400612","article-title":"Flutamide: an antiandrogen for advanced prostate cancer","volume":"24","author":"Goldspiel","year":"1990","journal-title":"Dicp"},{"issue":"4","key":"10.1016\/j.tice.2025.102807_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.yexcr.2009.11.020","article-title":"VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop","volume":"316","author":"Gonzalez-Moreno","year":"2010","journal-title":"Exp. Cell Res"},{"issue":"1","key":"10.1016\/j.tice.2025.102807_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24414-z","article-title":"Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2\/twist-VE-cadherin\/AKT pathway in human prostate cancer PC-3 cells","volume":"12","author":"Han","year":"2022","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.tice.2025.102807_bib13","doi-asserted-by":"crossref","first-page":"13689","DOI":"10.3390\/ijms232213689","article-title":"Mechanism of resveratrol-induced programmed cell death and new drug discovery against cancer: a review","volume":"23","author":"Jang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tice.2025.102807_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1665-2681(19)31595-9","article-title":"Acute and fulminant hepatitis induced by flutamide: case series report and review of the literature","volume":"10","author":"Javier","year":"2011","journal-title":"Ann. Hepatol."},{"issue":"1","key":"10.1016\/j.tice.2025.102807_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12885-015-1119-y","article-title":"Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-\u03b21\/Smads signaling pathway mediated Snail\/E-cadherin expression","volume":"15","author":"Ji","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.tice.2025.102807_bib16","first-page":"25","article-title":"Resveratrol downregulates PI3K\/Akt\/mTOR signaling pathways in human U251 glioma cells","volume":"8","author":"Jiang","year":"2009","journal-title":"J. Exp. Ther. Oncol."},{"issue":"3","key":"10.1016\/j.tice.2025.102807_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/157489207782497172","article-title":"The androgen receptor as putative therapeutic target in hormone-refractory prostate cancer","volume":"2","author":"Kageyama","year":"2007","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"issue":"10","key":"10.1016\/j.tice.2025.102807_bib18","first-page":"3323","article-title":"Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells","volume":"31","author":"Kai","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.tice.2025.102807_bib19","unstructured":"Key Statistics for Prostate Cancer: American Cancer Society; [updated January 12, 2023December 2023]. Available from: \u3008https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about\/key-statistics.html\u3009."},{"issue":"11","key":"10.1016\/j.tice.2025.102807_bib20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","article-title":"Characterising the castration-resistant prostate cancer population: a systematic review","volume":"65","author":"Kirby","year":"2011","journal-title":"Int J. Clin. Pr."},{"issue":"2","key":"10.1016\/j.tice.2025.102807_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.34172\/ijbsm.2022.11","article-title":"The oxidative and cytotoxic effects of resveratrol compared with cisplatin in the LNCap prostate cancer cell line","volume":"7","author":"Kojoeiyan Jafari","year":"2022","journal-title":"Int J. Basic Sci. Med"},{"issue":"3","key":"10.1016\/j.tice.2025.102807_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/1874467215666220616145216","article-title":"Resveratrol in cancer treatment with a focus on breast cancer","volume":"16","author":"Kowsari","year":"2023","journal-title":"Curr. Mol. Pharm."},{"issue":"10","key":"10.1016\/j.tice.2025.102807_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317715039","article-title":"Prolonged exposure of resveratrol induces reactive superoxide species\u2013independent apoptosis in murine prostate cells","volume":"39","author":"Kumar","year":"2017","journal-title":"Tumor Biol."},{"issue":"3","key":"10.1016\/j.tice.2025.102807_bib24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.tice.2025.102807_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4162\/nrp.2021.15.1.12","article-title":"Synergistic anticancer activity of resveratrol in combination with docetaxel in prostate carcinoma cells","volume":"15","author":"Lee","year":"2021","journal-title":"Nutr. Res Pr."},{"issue":"1","key":"10.1016\/j.tice.2025.102807_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4162\/nrp.2021.15.1.12","article-title":"Synergistic anticancer activity of resveratrol in combination with docetaxel in prostate carcinoma cells","volume":"15","author":"Lee","year":"2021","journal-title":"Nutr. Res Pr."},{"key":"10.1016\/j.tice.2025.102807_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","article-title":"MT1 and MT2 melatonin receptors: a therapeutic perspective","volume":"56","author":"Liu","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"7","key":"10.1016\/j.tice.2025.102807_bib28","first-page":"2416","article-title":"Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor\/phosphatidylinositol 3\u2032-kinase\/protein kinase B in prostate cancer cells","volume":"9","author":"Mabjeesh","year":"2003","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.tice.2025.102807_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101684","article-title":"Novel combination therapy of prostate cancer cells with arsenic trioxide and flutamide: an in-vitro study","volume":"74","author":"Mirzaei","year":"2022","journal-title":"Tissue Cell"},{"issue":"4","key":"10.1016\/j.tice.2025.102807_bib30","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1007\/s11033-023-08251-5","article-title":"The role of hypoxia on prostate cancer progression and metastasis","volume":"50","author":"Mohamed","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tice.2025.102807_bib31","unstructured":"Prostate: GLOBOCAN 2020; 2020 [Available from: \u3008https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/27-Prostate-fact-sheet.pdf\u3009."},{"issue":"12","key":"10.1016\/j.tice.2025.102807_bib32","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1158\/1078-0432.CCR-07-0810","article-title":"\"No Turning Bax\" in the combined battle against prostate cancer","volume":"13","author":"Rajendran","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.tice.2025.102807_bib33","doi-asserted-by":"crossref","DOI":"10.52711\/0974-360X.2021.00782","article-title":"Flutamide loaded polymeric nanoparticles for prostate cancer:a review","author":"Rao","year":"2021","journal-title":"Res. J. Pharm. Technol."},{"issue":"1","key":"10.1016\/j.tice.2025.102807_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.tice.2025.102807_bib35","article-title":"Acute liver failure and liver transplantation secondary to flutamide treatment in a prostate cancer patient","volume":"33","author":"Rojas","year":"2020","journal-title":"Urol. Case Rep."},{"issue":"17","key":"10.1016\/j.tice.2025.102807_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"1-2","key":"10.1016\/j.tice.2025.102807_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1383-5718(01)00232-7","article-title":"Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage","volume":"496","author":"Sgambato","year":"2001","journal-title":"Mutat. Res"},{"issue":"1","key":"10.1016\/j.tice.2025.102807_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/jox11010002","article-title":"The effects of resveratrol on prostate cancer through targeting the tumor microenvironment","volume":"11","author":"Silk","year":"2021","journal-title":"J. Xenobiot."},{"issue":"6","key":"10.1016\/j.tice.2025.102807_bib39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbadis.2014.11.004","article-title":"Resveratrol and cancer: challenges for clinical translation","volume":"1852","author":"Singh","year":"2015","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"11","key":"10.1016\/j.tice.2025.102807_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111536","article-title":"Curcumin against Prostate Cancer: Current Evidence","volume":"10","author":"Termini","year":"2020","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.tice.2025.102807_bib41","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/mc.22642","article-title":"Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF)","volume":"56","author":"Vancauwenberghe","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"2","key":"10.1016\/j.tice.2025.102807_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/1120009X.2019.1707417","article-title":"Recent advances in natural therapeutic approaches for the treatment of cancer","volume":"32","author":"Wang","year":"2020","journal-title":"J. Chemother."},{"key":"10.1016\/j.tice.2025.102807_bib43","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.12659\/MSM.913290","article-title":"Resveratrol induces apoptosis in murine prostate cancer cells via hypoxia-inducible factor 1-alpha (HIF-1\u03b1)\/reactive oxygen species (ROS)\/P53 signaling","volume":"24","author":"Wang","year":"2018","journal-title":"Med Sci. Monit."},{"issue":"7","key":"10.1016\/j.tice.2025.102807_bib44","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.21873\/anticanres.13538","article-title":"Flutamide as an alternative anti-androgen agent and predictor of the efficacy of novel androgen receptor-targeted agents","volume":"39","author":"Yamaguchi","year":"2019","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.tice.2025.102807_bib45","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/1535-7163.MCT-05-0064","article-title":"A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells","volume":"4","author":"Yamanaka","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"24","key":"10.1016\/j.tice.2025.102807_bib46","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.2174\/0929867328666201228124038","article-title":"Resveratrol and prostate cancer: the power of phytochemicals","volume":"28","author":"Zaffaroni","year":"2021","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.tice.2025.102807_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8017073","article-title":"Flutamide induces hepatic cell death and mitochondrial dysfunction via inhibition of Nrf2-mediated heme oxygenase-1","volume":"2018","author":"Zhang","year":"2018","journal-title":"Oxid. Med Cell Longev."},{"issue":"6","key":"10.1016\/j.tice.2025.102807_bib48","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.tice.2025.102807_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12514","article-title":"Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1","volume":"52","author":"Zhou","year":"2019","journal-title":"Cell Prolif."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625000874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625000874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T14:03:31Z","timestamp":1741615411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816625000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"alternative-id":["S0040816625000874"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2025.102807","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing prostate cancer cells\u2019 sensitivity to flutamide by resveratrol: An in-vitro study","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2025.102807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102807"}}